ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL
Product details
Registration number: SIN14950P
Classification: Prescription Only
Active ingredients: Vedolizumab
Strength: 300 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
ATC code: L04AA33
HSA approval date: 12 February 2016
Manufacturer(s):
- PATHEON ITALIA S.P.A
- Takeda Pharmaceutical Company Ltd., Hikari plant
Manufacturing country/countries: ITALY; JAPAN
What are the HSA registration number and classification for ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14950P
Classification: Prescription Only
What active ingredients and strength are recorded for ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Vedolizumab
Strength: 300 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
Which manufacturers and countries are listed for ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- PATHEON ITALIA S.P.A
- Takeda Pharmaceutical Company Ltd., Hikari plant
Manufacturing country/countries: ITALY; JAPAN
Where can I look up ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14950P or the exact product name ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL. The general register link does not preselect this product.
What are the source dates for this ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14950P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)